Recommendations for investigations of drugs for rare diseases or conditions

21 U.S. Code § 360aa. Recommendations for investigations of drugs for rare diseases or conditions

(a) Request by sponsor; response by SecretaryThe sponsor of a drug for a disease or condition which is rare in the States may request the Secretary to provide written recommendations for the non-clinical and clinical investigations which must be conducted with the drug before—
(1)
it may be approved for such disease or condition under section 355 of this title, or
This document is only available to subscribers. Please log in or purchase access.